History of Recordati Group
History of Recordati Polska
R&D - Research and Development
Pharmaceutical preparations production
Over the counter drugs
Information for the patient
Benign prostatic hyperplasia
Work with us
Work with us
Current job offers
Report adverse reaction
Recordati offers a wide range of innovative medicines, mainly for cardiovascular and urological disorders, and unique treatments for rare diseases.
Dedicated to treating the most vulnerable. Recordati Rare Diseases, the Recordati company dedicated to treatments for rare diseases.
We are also present in the self-medication segment and have always been committed to the improvement of quality of life by offering succesful products with well-known brands.
New products, new clinical trials, new projects in new therapeutic areas: these are Recordati's commitments and are a fundamental premise for its growth.
Recordati is a respected international pharmaceutical group and partner of important companies. >>
Each person with a rare disease has the right to the best treatment. >>
Research & Development
With an eye on the future the Recordati group invests significantly in research and development. >>
Towards a global presence, a strategy of international development. >>
Committed to generating future value by enacting an intelligent partnering policy. >>
Share Price - Investors
“The most valuable currency in financial markets is reliable information”. (Michael Bloomberg, Mary Shapiro) >>
Recordati Polska sp. z o.o.
Królewska 16 Str.
00-103 Warsaw, Poland
Tel: +48 22 206 84 50
Prizes and awards